PUBLIC COMPANY
saveGE HEALTHCARE
USupdated 4mo ago
community read0 votes
pipeline
4
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
4Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- N/AMaternal Fetal Device Performance Twins
- —Data Collection of New Spectral CT Imaging Method
- N/ANMT EasyFit Sensor and Cable
- phase3Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- phase3A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
- N/APortrait Mobile Monitoring Solution V2.0 External Evaluation
- —GSI Cardiac on Revolution Apex - US
- —Clinical Data Collection On Advanced CT System
🐶 Hiring Signal
News
- GE HealthCare mulls $1B imaging chemicals maker deal: Financial TimesGE HealthCare is said to be on the cusp of buying out radiopharmaceutical developer Sofie Biosciences, according to a report by the Financial Times.fiercebiotech · 21d ago
- Monitoring System Correction: GE HealthCare Updates Use Instructions for Portrait Core Services SoftwarePatients monitored on Portrait Mobile devices may be discharged (removed) from the Portrait monitoring system during an update to the Portrait Core Services software.fda_medwatch · 1mo ago
- Early Alert: Portrait Core Services Software Issue from GE HealthCarePatients monitored on Portrait Mobile devices can be discharged (removed) from the Portrait monitoring system during an update to the Portrait Core Services software.fda_medwatch · 1mo ago
comments(0)
5-min edit window · permanent after that